Treatment and survival of patients with pancreatic ductal adenocarcinoma: 15-year national cohort.

Linn Såve NymoTor Åge MyklebustHanne HamreBjørn MøllerKristoffer Lassen

Published in: BJS open (2022)

Survival after resection increased substantially, as did national resection rates. Little development in the provision of CTx or survival was observed for non-resected patients.

Keyphrases

end stage renal disease
prognostic factors
quality improvement
ejection fraction
newly diagnosed
peritoneal dialysis
palliative care
free survival
escherichia coli
patient reported outcomes
combination therapy